Admission: 4basebio UK Societas
4basebio UK Societas (4bb) is a specialist life sciences company focused on supplying therapeutic DNA for gene therapies and DNA vaccines and also for providing solutions for effective and safe delivery of these DNA based products to patients.
The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing GMP grade DNA, suitable for use in gene therapies and DNA vaccines. 4bb intends to collaborate with partners to facilitate the functional validation of its DNA based products and gene delivery solutions and, in doing so, aspires to develop a pipeline of promising gene therapy candidates.
Crowe's role and team
Client quote
"The Capital Markets team at Crowe were extremely professional and efficient throughout the transaction. We would certainly recommend them to other life science companies looking to list in London."
Heikki Lanckriet, Chief Executive Officer, 4basebio UK Societas
